What’s more, it also indicated that the activation of PI3K/AKT/mTOR was a complicated process, and further molecular biological, pathological and biochemical experiments were needed to support the prognosis of PI3K/AKT/mTOR pathway members in ccRCC. This evidence concerns the gene MTOR and nonpapillary renal cell carcinoma.